KRT14 and breast cancer: Since mice with the tissue-specific Orp3-KO (Orp3fl/fl × K14-Cretg) did not develop tumors over a period of 2 years (not shown), we used the above described BBN-induced BC progression model to elucidate potential contribution of Orp3 to BC progression.